Prosecution Insights
Last updated: August 18, 2026

Examiner: CONNORS, ALEXANDRA F

Tech Center 1600 • Art Units: 1631 1632 1634 1638

This examiner grants 23% of resolved cases

Performance Statistics

23.1%
Allow Rate
-36.9% vs TC avg
154
Total Applications
+44.3%
Interview Lift
1524
Avg Prosecution Days
Based on 108 resolved cases, 2023–2026

Rejection Statute Breakdown

3.5%
§101 Eligibility
13.7%
§102 Novelty
46.2%
§103 Obviousness
27.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18245128 COMPOSITIONS AND METHODS OF USE FOR INFUSIBLE EXTRACELLULAR MATRIX Final Rejection The Regents of the University of California
18051653 TCF7L2 MEDIATED REMYELINATION IN THE BRAIN Final Rejection University of Rochester
16105625 METHOD OF PRODUCING THREE-DIMENSIONAL CELL TISSUE Final Rejection TOPPAN Holdings Inc.
19361681 METHODS AND COMPOSITIONS FOR PRODUCING GRANULOSA-LIKE CELLS Final Rejection President and Fellows of Harvard College
16314471 PROPHYLACTIC OR THERAPEUTIC AGENT FOR ORGAN FIBROSIS Non-Final OA TOHOKU UNIVERSITY
17224831 METHODS OF TREATING INFLAMMATION Non-Final OA University of South Florida
16794723 Transcription Factor Mediated Programming Towards Megakaryocytes Non-Final OA Cambridge Enterprise Limited
17416311 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY Final Rejection THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
16971995 METHODS AND COMPOSITIONS COMPRISING CART AND A SMAC MIMETIC Final Rejection THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
16968504 PROMOTING AND PROTECTING FUNCTIONAL BETA CELL MASS BY SYNTAXIN 4 ENRICHMENT Non-Final OA CITY OF HOPE
17906150 METHOD FOR TREATING INFLAMMATORY BOWEL DISEASE II Final Rejection Mesoblast International Sárl

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month